These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35788344)

  • 1. Association of Proton Pump Inhibitor Use With All-Cause and Cause-Specific Mortality.
    Lo CH; Ni P; Yan Y; Ma W; Joshi AD; Nguyen LH; Mehta RS; Lochhead P; Song M; Curhan GC; Cao Y; Chan AT
    Gastroenterology; 2022 Oct; 163(4):852-861.e2. PubMed ID: 35788344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study.
    Foresta A; Fernandez LO; Torrigiani G; Schena S; Roncaglioni MC; Nobili A; Tettamanti M; Franchi C; Fortino I; Succurro E; Sesti G; Baviera M
    Drugs Aging; 2024 Mar; 41(3):239-249. PubMed ID: 38367169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population-based cohort study.
    Zeng R; Ma Y; Zhang L; Luo D; Jiang R; Wu H; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Sha W; Chen H
    Elife; 2024 Jul; 13():. PubMed ID: 39012339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes.
    Geng T; Chen JX; Zhou YF; Lu Q; Wan Z; Liu L; Pan A; Liu G
    J Clin Endocrinol Metab; 2023 May; 108(6):e216-e222. PubMed ID: 36573284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
    Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
    Brown JP; Tazare JR; Williamson E; Mansfield KE; Evans SJ; Tomlinson LA; Bhaskaran K; Smeeth L; Wing K; Douglas IJ
    Br J Clin Pharmacol; 2021 Aug; 87(8):3150-3161. PubMed ID: 33393677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mortality Risk of Proton Pump Inhibitors in 1.9 Million US Seniors: An Extended Cox Survival Analysis.
    Baik SH; Fung KW; McDonald CJ
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):e671-e681. PubMed ID: 33453399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort study.
    Douwes RM; Gomes-Neto AW; Eisenga MF; Van Loon E; Schutten JC; Gans ROB; Naesens M; van den Berg E; Sprangers B; Berger SP; Navis G; Blokzijl H; Meijers B; Bakker SJL; Kuypers D
    PLoS Med; 2020 Jun; 17(6):e1003140. PubMed ID: 32542023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts.
    He Q; Huang C; Qin X; Yu Y; Tang D; Huang J; Kuo ZC; Ling Y; Mao D; Xia B; Li W; Lu K; Yang M; He Y; Meng W; Yuan J; Pan Y
    Int J Cancer; 2023 Sep; 153(5):942-949. PubMed ID: 37232081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children.
    Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
    JAMA Pediatr; 2021 Apr; 175(4):394-403. PubMed ID: 33555324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
    Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP
    Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients.
    Zeng Y; Liu L; Zhu L; Zhan X; Peng F; Feng X; Zhou Q; Zhang Y; Wang Z; Liang J; Li J; Wen Y
    Ren Fail; 2022 Dec; 44(1):407-414. PubMed ID: 35236240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.
    Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
    JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
    Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
    J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study.
    Xie Y; Bowe B; Yan Y; Xian H; Li T; Al-Aly Z
    BMJ; 2019 May; 365():l1580. PubMed ID: 31147311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts.
    Xia B; Yang M; Nguyen LH; He Q; Zhen J; Yu Y; Di M; Qin X; Lu K; Kuo ZC; He Y; Zhang C; Meng W; Yuan J
    Gastroenterology; 2021 Dec; 161(6):1842-1852.e10. PubMed ID: 34389338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Fusaro M; D'Arrigo G; Pitino A; Iervasi G; Tentori F; Robinson B; Aghi A; Bieber B; Mccullogh K; Fabris F; Plebani M; Giannini S; Gallieni M; Tripepi G
    J Bone Miner Res; 2019 Dec; 34(12):2238-2245. PubMed ID: 31365145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.
    Yuan J; He Q; Nguyen LH; Wong MCS; Huang J; Yu Y; Xia B; Tang Y; He Y; Zhang C
    Gut; 2021 Jun; 70(6):1070-1077. PubMed ID: 32989021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.